Status:

TERMINATED

A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD

Lead Sponsor:

Jazz Pharmaceuticals

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine whether ODSH, when added to conventional treatment, is more effective in treating COPD exacerbations than conventional therapy alone.

Detailed Description

The management of acute exacerbations of COPD today is qualitatively the same as it was 40 years ago: bronchodilators, corticosteroids, and antibiotics. Because of the prominent pathophysiological rol...

Eligibility Criteria

Inclusion

  • Male and female patients (40 years of age or older) with an established diagnosis of COPD based upon medical history who are being admitted to the hospital to treat an exacerbation of COPD;
  • Normal prothrombin time and activated partial thromboplastin time; Platelet count; hemoglobin and hematocrit

Exclusion

  • Certain diseases such as:
  • asthma;
  • left heart failure or pulmonary embolism;
  • lung cancer;
  • pneumonia
  • liver or kidney disease
  • blood clotting disorder
  • Positive HIV or hepatitis tests
  • GI bleeding, physical trauma with bleeding, any disease with bleeding within 60 days of study entry
  • Certain medications such as:
  • Plavix®
  • Warfarin
  • Heparin therapy
  • Certain antibiotics
  • Exacerbations that are too severe (requiring intubation and mechanical ventilation)
  • Women of child-bearing potential, pregnancy or breast-feeding
  • Unable or unwilling to provide informed consent and follow study procedures.

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

158 Patients enrolled

Trial Details

Trial ID

NCT00457951

Start Date

April 1 2007

End Date

October 1 2009

Last Update

December 2 2021

Active Locations (38)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (38 locations)

1

Pulmonary Consultants & Primary Care

Orange, California, United States, 92868

2

Wellstar Kennestone Hospital

Marietta, Georgia, United States, 30060

3

Louisiana State University Health Sciences Center in Shreveport

Shreveport, Louisiana, United States, 71130

4

Washington Universtiy School of Medicine

St Louis, Missouri, United States, 63110